Details for Patent: 11,060,093
✉ Email this page to a colleague
Which drugs does patent 11,060,093 protect, and when does it expire?
Patent 11,060,093 protects OXLUMO and is included in one NDA.
This patent has twenty-nine patent family members in eighteen countries.
Summary for Patent: 11,060,093
Title: | Methods and compositions for the specific inhibition of glycolate oxidase (HAO1) by double-stranded RNA |
Abstract: | This invention relates to compounds, compositions, and methods useful for reducing Glycolate Oxidase (HAO1) target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents. |
Inventor(s): | Brown; Bob D. (Cambridge, MA), Dudek; Henryk T. (Cambridge, MA) |
Assignee: | Dicerna Pharmaceuticals, Inc. (Lexington, MA) |
Application Number: | 16/545,149 |
Patent Claim Types: see list of patent claims | Use; Composition; Compound; |
Drugs Protected by US Patent 11,060,093
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alnylam Pharms Inc | OXLUMO | lumasiran sodium | SOLUTION;SUBCUTANEOUS | 214103-001 | Nov 23, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | Y | TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1 (PH1) | ⤷ Sign Up | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,060,093
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 3581654 | ⤷ Sign Up | LUC00218 | Luxembourg | ⤷ Sign Up |
European Patent Office | 3581654 | ⤷ Sign Up | PA2021008 | Lithuania | ⤷ Sign Up |
European Patent Office | 3581654 | ⤷ Sign Up | 301132 | Netherlands | ⤷ Sign Up |
European Patent Office | 3581654 | ⤷ Sign Up | 2021C/534 | Belgium | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |